baber/WOPTO huggingface dataset:
Patent AT-E224039-T1 (AT)
Inventor: GOEDECKE HARTMUT
IPC: F16L55/38
Filed: 1998-05-26
Granted: 2002-09-15
Abstract: The unit comprises a body (21) with carrier elements, which act as guides in the pipes. A gyroscope or circular platform is located in the body, as well as supply and processing units for measurements. The body is moved at a constant angle to the pipe axis (R), using a combination of carrier elements. The carrier elements consist of a radially rigid section (24,24',25,25') and a radially flexible section (22,22',23,26,26'). The sliding elements preferably consist of plastics sliding shoes. The radially flexible section preferably consists of polyurethane.
Patent AT-E301758-T1 (AT)
Inventor: SCHNELLE MANFRED
IPC: B21D5/02
Filed: 1998-07-20
Granted: 2005-08-15
Abstract: The sides of the hinge container (2) defining the U-shaped cavity have clamping flanges (8) parallel with the swivel axis of the hinge arm (3) and penetrated by screws (9). The threaded pins (10) of the clamping flanges each go through an internally threaded, square or rectangular anchor disc (11). When the hinge (1) is fixed, the clamping flanges rest on the outer surfaces of a profiled arm (7), and the anchor discs rest on the inner surfaces of the corresponding profiled arm. The flanks of the hinge container housing next to the two screws have sloping parts sloping from the clamping flanges towards the centre axis of the hinge container.
Patent AT-E289417-T1 (AT)
Inventor: HERMANN FRANZ
IPC: G01R23/02
Filed: 1998-10-06
Granted: 2005-03-15
Abstract: The method involves subjecting an analogue signal to digital filtering for conversion into the complex frequency plane, with periodic repetition of the filtering within a measuring space to provide a series of transformation intervals containing vectors (p0-pn) with amplitude and phase components. The signal frequency is determined from the phase difference between selected vector pairs (p0,p1) using a defined formula. The formula is F = fLinie +  DELTA FLinie(1/(2 pi ))( i=1n DELTA  phi i)/( i=1n DELTA ti, where  DELTA FLinie = 1/TFFT, fLinie is the frequency of the selected line from the amplitude spectrum of a single transformation interval. TFFT and  DELTA ti is the time between the selected vector pairs.
Patent AT-E265737-T1 (AT)
Inventor: PARTEL GEORG
IPC: H01F7/124
Filed: 1998-11-10
Granted: 2004-05-15
Abstract: The linear motor feeds an element (1) over a defined path when an electrical current is supplied to a coil (13) contained with the motor housing (5), for displacement of a sliding armature (2). This has at least one pivoted clamp element (3), for gripping the element, which is operated by the supplied current, simultaneous with the armature movement.
Patent AT-E260569-T1 (AT)
Inventor: KLINGENBERG ANDREAS DR RER NAT
IPC: A23L2/74
Filed: 1998-12-03
Granted: 2004-03-15
Abstract: Production of fruit and vegetable juice concentrates with a high polyphenol content and a low sugar and acid content comprises: (a) treating a fruit or vegetable juice or concentrate with a mixture of pectinases and cellulases, hemicellulases and/or proteases; (b) removing suspended solids by sedimentation and filtration; and (c) subjecting the filtrate to ultrafiltration using a membrane with a molecular weight cut-off of 2-20 kD. An Independent claim is also included for a fruit or vegetable juice concentrate with a polyphenol content of 70-150 g/l, an anthocyanin concentration of 2.5-5%, a mono- and disaccharide content of less than 5% and a water content of 50-70%.
Patent AT-E214707-T1 (AT)
Inventor: COSTANZO MICHAEL J
IPC: A61K31/70
Filed: 1993-12-07
Granted: 2002-04-15
Abstract: The present invention relates to a method of preparing BCH-189 and various analogues of BCH-189 from inexpensive precursors with the option of introducing functionality as needed. This synthetic route allows the stereoselective preparation of the biologically active isomer of these compounds,  beta -BCH-189 and related compounds. Furthermore, the stereochemistry at the nucleoside 4'-position can be controlled to produce enantiomerically-enriched  beta -BCH-189 and its analogues.
Patent AT-E243484-T1 (AT)
Inventor: SCHRIJVER FLOOR
IPC: A61F5/01
Filed: 1998-01-05
Granted: 2003-07-15
Abstract: An ankle brace for a lower leg, ankle and foot of a human having a medial part anatomically adapted to fit the lower leg, the ankle and the foot of a human and a lateral part. The medial part is flexible and includes a sole part adapted to extend beneath the foot. The lateral part is connected to the sole part of the medial part and is substantially more flexible than the medial part.
Patent AT-E218232-T1 (AT)
Inventor: BEHNAM NEDA
IPC: G06K19/073
Filed: 1998-03-10
Granted: 2002-06-15
Abstract: The invention concerns a method for carrying out a guarantee deposit between an owner-electronic purse (owner-PME) and a client-electronic purse (client-PME). The invention is characterised in that the method consists in producing in each PME a guarantee trace file with a guarantee-field and a recovery deadline-field. For each guarantee deposit operation, the method consists in: in a step of guarantee deposit collection, a balance file of the client-PME is debited of the amount of the deposit and the deposit amount and recovery deadline are posted in the PME deposit trace files, the balance file of the owner-PME not being credited with the deposit amount; in a recovery step, the client-PME balance file is credited with a refunding amount not more than the deposit amount, the owner-PME balance file being credited with the difference between the deposit amount and the refunding amount and the owner-PME balance file being credited with the deposit amount if the goods are not recovered.
Patent AT-E302602-T1 (AT)
Inventor: HOPPE UDO
IPC: A61K8/30
Filed: 1998-04-03
Granted: 2005-09-15
Abstract: A method for the prophylaxes and treatment of psoriasis, allergies and auto-immune disorders of the skin, the treatment of sensitive skin, or a combination thereof, which comprises applying cis-6-hexadecenoic acid, or a salt or ester thereof.
Patent AT-E270050-T1 (AT)
Inventor: POPPER GERHARD
IPC: A23K50/48
Filed: 1998-02-26
Granted: 2004-07-15
Abstract: A sterilized, gelled emulsion pet food product which contains protein, lipid, carbohydrate and a binder. The binder is made up of chitosan or a mixture of chitosan and a polyphosphate. The emulsion product is less susceptible to cook out of fats and starch during sterilization and has a firm, relatively elastic texture. The sterilized, gelled emulsion product may be provided in the form of a chunks-in-liquid pet food.
Patent AT-E300990-T1 (AT)
Inventor: FUKUDA TATSUYA
IPC: B01D24/00
Filed: 1998-06-26
Granted: 2005-08-15
Abstract: A leukocyte-removing filter medium which comprises a matrix and ultra-fine fibers having a fiber diameter of less than 1.0  mu m and not less than 0.01  mu m which contains ultra-fine fibers in an amount of less than 50 wt% and not less than 0.1 wt%, the degree of curvature of the ultra-fine fibers being 1.2 or more, and/or the ultra-fine fibers form pores having a roundness of 1.7 or less.
Patent AT-E204788-T1 (AT)
Inventor: BREITENBACH JOERG
IPC: B01J2/20
Filed: 1998-05-13
Granted: 2001-09-15
Abstract: A process for the continuous production of solid, particulate preparations of bioactive substances, in which the bioactive substances are homogeneously dispersed in a matrix of thermoplastic auxiliaries, in a screw extruder divided into a plurality of zones, wherein there is firstly melting of the matrix auxiliaries and mixing of the bioactive components with the matrix auxiliaries in a heatable zone, after which the mixture is cooled, precomminuted and finely ground in a cooling zone, the screw geometry in the cooling zone being selected so that the cooling zone consists of a conveying zone, a mixing zone and a kneading zone.
Patent AT-E289980-T1 (AT)
Inventor: GESSNER NORBERT
IPC: B67D1/04
Filed: 1998-06-23
Granted: 2005-03-15
Abstract: The invention relates to a container for fluids having a volume (2a) which can be filled with a fluid, and emptied by pressurizing the fluid by subjecting it to internal gas pressure. The invention is characterized in that the container has a valve device (7a) for filling the volume (2a) with the fluid, while the internal gas pressure is generated by compressing a gas trapped in the container (1a). It is thus not necessary to fill the receptacle with pressure gas separately.
Patent AT-E251631-T1 (AT)
Inventor: VAN GULIK FRED EURODRUG LTD
IPC: C07D295/08
Filed: 1998-07-08
Granted: 2003-10-15
Abstract: Diphosphonates or their salts between acids and linear, branch substituted and non-substituted, cyclic, heterocyclic and aromatic amino alcohols are used to treat osteoporosis. Pharmaceutical compositions and therapeutic methods of treating osteoporosis are described.
Patent AT-E232870-T1 (AT)
Inventor: ANDELL OVE
IPC: C07D487/04
Filed: 1998-08-21
Granted: 2003-03-15
Abstract: The invention relates to an organometallic compound comprising a central transition metal atom and a ligand coordinated thereto having a heteroatomic ring structure, characterized in that the ligand includes at least three nitrogen atoms, three of them being bonded to the same carbon atom.
Patent AT-E212473-T1 (AT)
Inventor: MAECKEL RAINER
IPC: H02H5/04
Filed: 1998-07-21
Granted: 2002-02-15
Abstract: The invention relates to a fuse element for a closed circuit, especially in motor vehicles, comprising a fuse which permanently interrupts the current when the current load exceeds the nominal current. The fuse element contains an additional heating element arranged nearby. The invention also relates to a method for operating the fuse element and a suitable circuit in a heating element is grounded in relation to the vehicle electrical system from the source of current (1) outwards behind the fuse (4) parallel to the consumer (10) by means of a switching element (7). Said switching element being controlled by a control unit for regulating heat output and/or by a tripping element (8, 7).
Patent AT-E206213-T1 (AT)
Inventor: RAUS AXEL
IPC: G01R31/00
Filed: 1998-11-13
Granted: 2001-10-15
Abstract: When electromagnetic compatibility is measured according to ENV 50142 with a purely capacitative coupling, the test specimen must be brought to the voltage potential. This results in dangers and an insufficient amount of influence of internal conductors in shielded cables. If a transformer is used, a large amount of power is magnetically injected into internal conductors and it is possible to avoid a voltage potential on said specimen. The inventive method and device can be used in all measurements of electromagnetic compatibility and is particularly useful for shielded cables.
Patent AT-E243337-T1 (AT)
Inventor: GRASSY GERARD
IPC: C07B61/00
Filed: 1998-12-29
Granted: 2003-07-15
Abstract: The present invention is concerned with a computer-aided method for the provision, identification and description of molecules exhibiting a desired behaviour, more particularly in the pharmaceutical sector, employing a molecular modelling step, a combinatorial library building step and a step of selecting potentially useful molecules, said method including a step whereby the candidate molecules are filtered using a dynamic filter representing constraints of conformational variations which the molecules must satisfy in order to exhibit said activity.
Patent AT-E316135-T1 (AT)
Inventor: BOSSLET KLAUS DR
IPC: A61K39/00
Filed: 1991-02-22
Granted: 2006-02-15
Abstract: The MAbs are derived from neuroectodermal tumours (e.g. small-celled lung carcinoma, SCLC), melanoma, neuroblastoma or cultures of cell lines of these tumours. The pred. antigens are derived from (a) SCLC cell lines that have a non-reduced SDS-PAGE molecular weight of 170 +/- 10 kDa, 140 +/- kDa, 105 +/- 10 kDa, 67 +/- 10 kDa and 50 +/- 10 kDa, or (b) antigens obtained from human body fluids, which have a non-reduced SDS-PAGE molecular weight of 75 +/- 5 kDa, 105 +/- 5 kDa, 180 +/- 20 kDa and 240 +/-29 kDa. Specifically claimed are the MAbs BW SCLC-1 and BW SCLC-2, and hybridoma cell lines producing them (ECACC deposit no. 90022109 and 90022110 respectively).
Patent AT-E361054-T1 (AT)
Inventor: FATH BETTINA
IPC: C07C217/08
Filed: 1999-02-24
Granted: 2007-05-15
Abstract: Aqueous hair treatment agent contains a mixture of 0.1-20 wt.% esterquat(s) (I) and 0.1-20 wt.% mono- and/or oligosaccharide(s) (II). Aqueous hair treatment agent contains a mixture of 0.1-20 wt.% esterquat(s) of formula (I) and 0.1-20 wt.% mono- and/or oligosaccharide(s) (II); R<1>, R<2> = 8-22 C (hydroxy)alk(en)yl; R<3>, R<4> = 1-3 C alkyl or -CH2-CH2-O-(EO)z-H; EO = an ethylene oxide unit; x, y, z = 0-5; Y<-> = an anion.
Patent AT-E254436-T1 (AT)
Inventor: HENSSGE ERNST JOACHIM PROF DR
IPC: A61F2/00
Filed: 1999-07-28
Granted: 2003-12-15
Abstract: The cavities (6) are positioned around the edge (4)of at least one sheet metal plate (2). Several such metal plates are superimposed and welded to form a laminate. One or more sheet metal panels are back-tapered.(8). The surface of the sheet metal panels forming the outer surface of the endoprosthesis has a pre-set surface structure.
Patent AT-E262375-T1 (AT)
Inventor: WINTER MANFRED
IPC: B01J27/232
Filed: 1999-11-02
Granted: 2004-04-15
Abstract: Molded body for a chemical apparatus is formed of at least two closed frames and one or more pegs joining the frames. The frames are arranged at a distance from one another in one or more planes about a molded body axis vertical to the planes running through the mid-points of the frame. An Independent claim is also included for a process for pyrolysis of formyl alaninitrile or formamide in a tubular reactor in the presence of a molded body made of aluminum oxide impregnated with potassium carbonate.
Patent AT-E270998-T1 (AT)
Inventor: CALLAHAN STEVEN A
IPC: A44B19/16
Filed: 1994-05-18
Granted: 2004-07-15
Abstract: An arrangement for securing a boat canopy to a windshield assembly comprises providing the boat canopy with one or more struts (160) and releasably connecting the or each strut to a member of a side frame (110) of the windshield assembly by means of a quick release pin (146). The side frame comprises an extrusion (118) which defines a slot (131) and through holes (117,127). A fitting (140) is secured to the end of the strut (160) and includes arms (142,144) which define through holes (142,145) to accommodate the pin (146). <IMAGE>
Patent AT-E292178-T1 (AT)
Inventor: HEO WON-DO
IPC: C12N5/04
Filed: 1999-01-08
Granted: 2005-04-15
Abstract: PURPOSE: A gene transferred plant which shows multi-diseases resistance to a wide range of pathogenic organisms of plant by being transferred to heterogeneous genes of soybean calmodulin(SCaM) such as SCaM4 or SCaM5 and plant cell thereof are provided. CONSTITUTION: A gene transferred plant, cells or offspring thereof express genes encoding SCaM4, which is deposited on KCTC(Korean Collection for Type Cultures) as a deposit number of 0543BP and has a sequence number of 1, or soybean calmodulin 5(SCaM5), which is deposited on KCTC as a deposit number of 0544BP and has a sequence number of 3. The multi-diseases resistance of higher plant life regarding one or more of the pathogenic organisms of plant is improved by transferring the gene transferred plant using two SCaM4 or SCaM5 gene vectors into the genes encoding SCaM4 or SCaM5.
Patent AT-E438588-T1 (AT)
Inventor: WATSON RICHARD WILLIAM
IPC: C01B17/16
Filed: 1999-06-23
Granted: 2009-08-15
Abstract: Sulphur vapour is formed by partial oxidation of hydrogen sulphide. A burner is operated so as to establish a flame in a furnace in or into which the burner fires. There is supplied to the flame from the first region of the mouth of the burner at least one flow of a first combustible gas comprising hydrogen sulphide. At least one second flow of a first oxidising gas is caused to issue from the mouth of the burner and mix in the flame with the first combustible gas. There is supplied to the flame from a second region of the mouth of the burner surrounding and spaced from the said first region at least one third flow of a second combustible gas comprising hydrogen sulphide. At least one fourth flow of a second oxidising gas is caused to issue from a region or regions of the mouth of the burner surrounded by said second region and mix in the flame with the second combustible gas. At least one fifth, outermost flow of a third oxidising gas is caused to mix in the flame with the second combustible gas. A resultant gas mixture including sulphur vapour, water vapour, sulphur dioxide, hydrogen and residual hydrogen sulphide is withdrawn from the furnace. <IMAGE>
Patent AT-E312662-T1 (AT)
Inventor: BERREBI GEORGES
IPC: B01J20/18
Filed: 1999-04-09
Granted: 2005-12-15
Abstract: A material (I) comprises a first powdery solid (A) selected from zeolites Y with faujasite structure, activated charcoal, carbon fibers; and a second solid (B) (different to (A)) coating (A) and which is selected form zeolites type ZSM5, MZM41 or SAPO, and activated charcoals. An Independent claim is also included for a method of decreasing the alcohol content of an alcoholic drink by contacting the alcoholic drink with (I).
Patent AT-E325879-T1 (AT)
Inventor: LOOS ULRICH
IPC: G01N33/566
Filed: 1999-01-13
Granted: 2006-06-15
Abstract: Verfahren zur Herstellung eines gereinigten rekombinanten TSH-Rezeptorpräparats (rTSHR-Präparat), bei dem man einen rekombinanten Fusions-TSH-Rezeptor herstellt, der zwischen der Aminosäuresequenz des funktionalen TSH-Rezeptors und einem an eine feste Phase bindbaren peptidrest eine eingeschobene zusätzliche Aminosäuresequenz aufweist, die mit Hilfe einer geeigneten Protease, z.B. Faktor Xa, selektiv von der Aminosäuresequenz des funktionalen TSH-Rezeptors abspaltbar ist, den Fusionsrezeptor an eine geeignete Festphase bindet und durch Waschen von kontaminierenden Bestandteilen befreit, gegebenenfalls in gebundener Form markiert, den an die Festphase gebundenen Fusionsrezeptor mit einer Protease proteolytisch vom festphasengebundenen Rest des Fusionsrezeptors abdaut, und das erhaltene gereinigte rTSHR-Präparat gewinnt. Das gereinigte bzw. gereinigte und markierte humane rTSHR-Präparat kann zur oralen Tolerisierung und zur Schaffung eines neuen Immunpräzipitationsassays zur Bestimmung von Anti-TSHR-Autoantikörpern verwendet werden.
Patent AT-E279948-T1 (AT)
Inventor: SKURTVEIT ROALD
IPC: A61K49/00
Filed: 1999-04-22
Granted: 2004-11-15
Abstract: Ultrasonic visualisation of a subject, particularly of perfusion in the myocardium and other tissues, is performed using novel gas-containing contrast agent preparations which provide controllable and temporary growth of the gas phase in vitro following administration and can therefore act as deposited perfusion tracers. The preparations comprise an injectable aqueous gas dispersion and an administrable substance or substances capable of destabilising the dispersed gas to provide temporary growth thereof. In cardiac perfusion imaging the preparations may advantageously be coadministered with vasodilator drugs such as adenosine in order to enhance the differences between return signal intensity from normal and hypoperfused myocardial tissue respectively.
Patent AT-E256497-T1 (AT)
Inventor: MORRISON DENNIS R
IPC: A61K9/127
Filed: 1999-05-14
Granted: 2004-01-15
Abstract: Methods are provided for forming spherical multilamellar microcapsules having alternating hydrophilic and hydrophobic liquid layers, surrounded by flexible, semi-permeable hydrophobic or hydrophilic outer membranes which can be tailored specifically to control the diffusion rate. The methods of the invention rely on low shear mixing and liquid-liquid diffusion process and are particularly well suited for forming microcapsules containing both hydrophilic and hydrophobic drugs. These methods can be carried out in the absence of gravity and do not rely on density-driven phase separation, mechanical mixing or solvent evaporation phases. The methods include the process of forming, washing and filtering microcapsules. In addition, the methods contemplate coating microcapsules with ancillary coatings using an electrostatic field and free fluid electrophoresis of the microcapsules. The microcapsules produced by such methods are particularly useful in the delivery of pharmaceutical compositions.
Patent AT-E374846-T1 (AT)
Inventor: SHINDO YUICHIRO
IPC: C01G55/00
Filed: 1999-07-14
Granted: 2007-10-15
Abstract: There is provided a high-purity ruthenium sputtering target with a low impurity content, in particular producing extremely few particles, which is suitable for applications such as the formation of semiconductor thin films. The high-purity ruthenium sputtering target is manufactured by feeding crude ruthenium powder into a sodium hydroxide solution; blowing an ozone-containing gas while or after blowing chlorine gas into the solution to form ruthenium tetroxide; absorbing the ruthenium tetroxide in a hydrochloric acid solution or a mixed solution of hydrochloric acid and ammonium chloride, and evaporating the solution to dryness; sintering the resultant ruthenium salt in a hydrogen atmosphere to form high-purity ruthenium powder; and hot-pressing the ruthenium powder into a sputtering target. The content of each element of carbon, oxygen, and chlorine in the sputtering target obtained is 100 ppm or below.
Patent AT-E281185-T1 (AT)
Inventor: LIDGREN LARS KE ALVAR
IPC: A61L2/08
Filed: 1999-05-27
Granted: 2004-11-15
Abstract: A method for manufacturing the powder: component for a cement for medical use includes a liquid component containing a polymerizable substance and a powder component containing a plastic substance and an X-ray contrast medium. The liquid component and the powder component are mixed for providing a setting mass which is set to form the cement. In order to prevent the formed cement from releasing particles wearing on articulating or bearing surfaces adjacent ;the point of cementation, a water soluble, non-ionic X-ray contrast medium is mixed with the plastic substance, and for minimizing the risk of damaging the powder component during the sterilization, sterilizing by radiation of the powder component containing the X-ray contrast medium is carried through a negative pressure or in an inert gas atmosphere.
Patent AT-E217029-T1 (AT)
Inventor: SCHMIDT HANS-PETER
IPC: C21D1/76
Filed: 1999-08-13
Granted: 2002-05-15
Abstract: When metallic parts are annealed in an inert low-hydrogen atmosphere, carbon deposits often remain on the surface of said parts. The inventive method and device allow for controlled dampening of the dry inert low-hydrogen atmosphere and transformation of carbon deposits into volatile carbon oxides. Said method and device provide a soot-free annealing process and substantially prevent any mass transfer with the material.
Patent AT-E235247-T1 (AT)
Inventor: NICOL CHRISTINE
IPC: A23K1/18
Filed: 1999-10-06
Granted: 2003-04-15
Abstract: A composition comprising fat, fibre and, optionally, a stomach antacid is used in the treatment, prevention and/or amelioration of stereotypic behaviours such as crib-biting, stall walking, wind-sucking or wood chewing in animals such as the horse. The preferred sources of fat are highly polyunsaturated vegetable oils such as corn oil, soya oil or processed canola oil, or more saturated fats such as coconut oil, palm oil, or sunflower oil. The preferred source of fibre is any carbohydrate which is not digestible by mammalian enzymes, for example, alfalfa hay, which also contains a high protein content. At least some of the fibre should be in chopped form in the range 1-7 cm in length. Suitable stomach antacids include (a) alkaline salt compounds which can neutralise stomach acid such as aluminum phosphate and dihydro-aluminum sodium carbonate, (b) proton pump inhibitors such as the substituted benzimidazole compound, omeprazole, or (c) histamine type-2 antagonists such as ranitidine or cimetidine. Animal stereotypy may also be treated by controlling the pH of the animal's stomach using a proton pump inhibitor, such as, omeprazole, or a histamine type-2 antagonists.